Skip to main navigation
Skip to search
Skip to main content
Discover Research at University College Cork Home
Search content at Discover Research at University College Cork
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Anti-adhesion molecule therapy for inflammatory bowel disease
Subrata Ghosh
, Remo Panaccione
University of Calgary
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anti-adhesion molecule therapy for inflammatory bowel disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Inflammatory Bowel Disease
100%
Integrin
100%
Cell Adhesion Proteins
100%
Inflammation
100%
Lymphocyte
66%
Adhesive Agent
66%
TNF Inhibitor
66%
Diseases
33%
Gut
33%
Endothelial Cell
33%
Serositis
33%
Tumor Necrosis Factor
33%
Patient with Inflammatory Bowel Disease
33%
Recurrent Disease
33%
Crohn's Disease
33%
Patient with Crohn's Disease
33%
Monoclonal Antibody
33%
Intercellular Adhesion Molecule 1
33%
Natalizumab
33%
Mucosal Addressin Cell Adhesion Molecule 1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Inflammatory Bowel Disease
100%
Cell Adhesion Proteins
100%
Integrin
75%
Crohn's Disease
50%
Adhesive Agent
50%
Tumor Necrosis Factor Inhibitor
50%
Diseases
25%
Tumor Necrosis Factor
25%
Monoclonal Antibody
25%
Recurrent Disease
25%
Intercellular Adhesion Molecule 1
25%
Natalizumab
25%
Mucosal Addressin Cell Adhesion Molecule 1
25%